Duke-NUS Medical School

Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials

Singapore, August 01, 2020:  (ACN Newswire) - Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving "First…

4 years ago